Lyra Therapeutics, Inc.
LYRA
$0.0873
$0.00080.93%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -21.40% | -23.51% | -22.52% | -15.22% | 0.20% |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -13.13% | 45.48% | -16.69% | 12.43% | -12.74% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | -20.97% | -21.59% | -22.37% | -14.67% | -0.09% |
|
|||||
Total Current Assets | -20.97% | -21.59% | -22.37% | -14.67% | -0.09% |
Net Property, Plant & Equipment | -4.44% | -3.61% | -53.14% | 40.06% | 418.76% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 0.05% | 0.00% | -25.53% | 6.87% | -71.73% |
Total Assets | -15.76% | -16.73% | -33.17% | -0.75% | 18.27% |
|
|||||
Total Accounts Payable | -48.56% | -53.89% | 74.79% | -9.17% | -38.05% |
Total Accrued Expenses | -33.97% | -47.55% | -39.40% | 23.50% | -26.32% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 2.95% | -6.23% | -5.22% | -17.11% | 287.31% |
Total Finance Division Other Current Liabilities | -4.43% | 38.59% | 198.79% | -54.34% | 67.38% |
Total Other Current Liabilities | -4.43% | 38.59% | 198.79% | -54.34% | 67.38% |
Total Current Liabilities | -15.53% | -22.42% | 2.95% | -4.45% | 1.88% |
|
|||||
Total Current Liabilities | -15.53% | -22.42% | 2.95% | -4.45% | 1.88% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -3.39% | -3.57% | -2.63% | 55.53% | 338.86% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 0.00% | 0.10% | -0.78% | -1.59% | -0.64% |
Total Liabilities | -5.82% | -8.60% | -0.65% | 20.39% | 46.36% |
|
|||||
Common Stock & APIC | 0.48% | 0.36% | 0.40% | 2.63% | 5.34% |
Retained Earnings | -2.79% | -3.11% | -14.42% | -7.21% | -5.12% |
Treasury Stock & Other | -- | 600.00% | -116.00% | -24.24% | 571.43% |
Total Common Equity | -43.77% | -33.44% | -60.03% | -13.33% | 6.15% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -43.77% | -33.44% | -60.03% | -13.33% | 6.15% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -43.77% | -33.44% | -60.03% | -13.33% | 6.15% |
|